• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用反向对接技术鉴定杨梅苷抑制三阴性乳腺癌细胞迁移的潜在靶点

Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.

作者信息

Rachmi Eva, Purnomo Basuki Bambang, Endharti Agustina Tri, Fitri Loeki Enggar

机构信息

Department of Anatomy, Medical Faculty, Universitas Mulawarman, Samarinda.

Department of Urology, Medical Faculty, Universitas Brawijaya/dr. Saiful Anwar General Hospital.

出版信息

Porto Biomed J. 2020 Nov 24;5(6):e095. doi: 10.1097/j.pbj.0000000000000095. eCollection 2020 Nov-Dec.

DOI:10.1097/j.pbj.0000000000000095
PMID:33283065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7710241/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) tends to be aggressive and metastatic, characteristics attributable to its cellular migration capabilities. Afzelin is a chemical compound with anti-metastatic potentials. This study aimed to predict proteins involved in TNBC cell migration which could be inhibited by afzelin.

METHODS

The protein database was constructed from the Kyoto Encyclopedia of Genes and Genomes pathways collection which related to cell motility, then screened for druggability using SuperTarget and Therapeutic Target Database. The involvement of druggable proteins in the TNBC metastasis process was investigated through existing publications in The National Center for Biotechnology Information PubMed database. Inhibitory potential of afzelin toward target proteins was compared to the proteins' known-inhibitor, using the reverse docking method.

RESULTS

Ten proteins identified as potential targets of afzelin, with the top 3 being ERK2, KRas, and FAK, respectively. Afzelin's 3-O-rhamnoside group played a dominant role in forming hydrogen bonds with the target proteins. Further analysis with STRING suggested that afzelin might be able to inhibit chemotaxis and haptotaxis of TNBC cells.

CONCLUSIONS

Afzelin was predicted to inhibit TNBC cell motility, by targeting ERK2, KRas, and FAK activation.

摘要

背景

三阴性乳腺癌(TNBC)往往具有侵袭性和转移性,这些特征归因于其细胞迁移能力。阿夫泽林是一种具有抗转移潜力的化合物。本研究旨在预测参与TNBC细胞迁移且可被阿夫泽林抑制的蛋白质。

方法

蛋白质数据库由与细胞运动相关的京都基因与基因组百科全书通路集合构建而成,然后使用SuperTarget和治疗靶点数据库筛选其成药可能性。通过美国国立生物技术信息中心PubMed数据库中的现有出版物研究可成药蛋白质在TNBC转移过程中的参与情况。使用反向对接方法将阿夫泽林对靶蛋白的抑制潜力与蛋白质的已知抑制剂进行比较。

结果

鉴定出10种蛋白质为阿夫泽林的潜在靶点,其中排名前三的分别是ERK2、KRas和FAK。阿夫泽林的3 - O - 鼠李糖苷基团在与靶蛋白形成氢键中起主导作用。STRING的进一步分析表明,阿夫泽林可能能够抑制TNBC细胞的趋化性和趋触性。

结论

预计阿夫泽林通过靶向ERK2、KRas和FAK的激活来抑制TNBC细胞的运动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d23/7710241/2ba85aeb0dd5/pj9-5-e095-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d23/7710241/2ba85aeb0dd5/pj9-5-e095-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d23/7710241/2ba85aeb0dd5/pj9-5-e095-g002.jpg

相似文献

1
Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.使用反向对接技术鉴定杨梅苷抑制三阴性乳腺癌细胞迁移的潜在靶点
Porto Biomed J. 2020 Nov 24;5(6):e095. doi: 10.1097/j.pbj.0000000000000095. eCollection 2020 Nov-Dec.
2
Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.姜黄素及其纳米制剂:通过网络药理学、分子对接和实验验证确定三阴性乳腺癌靶点。
Front Pharmacol. 2022 Aug 8;13:920514. doi: 10.3389/fphar.2022.920514. eCollection 2022.
3
Afzelin induces immunogenic cell death against lung cancer by targeting NQO2.白花前胡乙素通过靶向 NQO2 诱导肺癌免疫原性细胞死亡。
BMC Complement Med Ther. 2023 Oct 27;23(1):381. doi: 10.1186/s12906-023-04221-3.
4
Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.网络药理学与实验验证探讨康莱特注射液治疗三阴性乳腺癌的作用及机制。
Drug Des Devel Ther. 2023 Mar 23;17:901-917. doi: 10.2147/DDDT.S397969. eCollection 2023.
5
Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.基于生物信息学和体外实验验证的石榴籽醇提物抗三阴性乳腺癌的分子机制
Medicine (Baltimore). 2023 Sep 15;102(37):e34835. doi: 10.1097/MD.0000000000034835.
6
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.紫草素通过miR-17-5p/PTEN/Akt途径抑制上皮-间质转化,从而抑制三阴性乳腺癌细胞的迁移和侵袭。
J Cancer. 2021 Jan 1;12(1):76-88. doi: 10.7150/jca.47553. eCollection 2021.
7
A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.查尔酮-丁香醛杂合体通过抑制 CKAP2 介导的 FAK 和 STAT3 磷酸化抑制三阴性乳腺癌细胞的增殖和迁移。
Phytomedicine. 2022 Jul;101:154087. doi: 10.1016/j.phymed.2022.154087. Epub 2022 Apr 1.
8
Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.柴胡皂苷 D 通过靶向β-catenin 信号通路抑制三阴性乳腺癌细胞生长。
Biomed Pharmacother. 2018 Dec;108:724-733. doi: 10.1016/j.biopha.2018.09.038. Epub 2018 Sep 21.
9
Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis.基于细胞黏附的三阴性乳腺癌整合生物信息学分析鉴定关键基因及上游调控因子。
Anticancer Res. 2023 Jul;43(7):2951-2964. doi: 10.21873/anticanres.16466.
10
Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.基于综合生物信息学分析鉴定与三阴性乳腺癌发病机制、转移及预后相关的潜在关键基因
Front Oncol. 2020 Jun 12;10:856. doi: 10.3389/fonc.2020.00856. eCollection 2020.

引用本文的文献

1
RPS6KA1 is a histone acetylation-related oncoprotein in acute myeloid leukemia which is targeted by afzelin.RPS6KA1 是急性髓系白血病中与组蛋白乙酰化相关的癌蛋白,阿夫唑嗪可靶向该蛋白。
BMC Cancer. 2024 Sep 27;24(1):1189. doi: 10.1186/s12885-024-12886-3.
2
Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin.探索桤木酮的综合神经保护和抗癌潜力。
Pharmaceuticals (Basel). 2024 May 28;17(6):701. doi: 10.3390/ph17060701.
3
Afzelin induces immunogenic cell death against lung cancer by targeting NQO2.白花前胡乙素通过靶向 NQO2 诱导肺癌免疫原性细胞死亡。

本文引用的文献

1
Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple-negative breast cancer epithelial cells through the RhoA/Rac1 pathway.Dock1和Elmo1的下调通过RhoA/Rac1途径抑制三阴性乳腺癌上皮细胞的迁移和侵袭。
Oncol Lett. 2018 Sep;16(3):3481-3488. doi: 10.3892/ol.2018.9077. Epub 2018 Jul 4.
2
Docking-based inverse virtual screening: methods, applications, and challenges.基于对接的反向虚拟筛选:方法、应用及挑战
Biophys Rep. 2018;4(1):1-16. doi: 10.1007/s41048-017-0045-8. Epub 2018 Feb 1.
3
Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size.
BMC Complement Med Ther. 2023 Oct 27;23(1):381. doi: 10.1186/s12906-023-04221-3.
4
Ameliorates High-Fat-Diet-Induced Obesity by Elevating Peripheral Thermogenic Signaling.通过提高外周产热信号来改善高脂肪饮食诱导的肥胖。
Molecules. 2022 Mar 2;27(5):1649. doi: 10.3390/molecules27051649.
印度尼西亚乳腺癌的分子亚型——与患者年龄和肿瘤大小无关
Asian Pac J Cancer Prev. 2018 Jan 27;19(1):161-166. doi: 10.22034/APJCP.2018.19.1.161.
4
The implication from RAS/RAF/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer.在表柔比星治疗的三阴性乳腺癌中,RAS/RAF/ERK信号通路的激活增加。
Oncotarget. 2017 Nov 21;8(64):108249-108260. doi: 10.18632/oncotarget.22604. eCollection 2017 Dec 8.
5
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.治疗靶点数据库更新 2018:丰富资源,促进靶向治疗的基础到临床研究。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1121-D1127. doi: 10.1093/nar/gkx1076.
6
αβ integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo.αβ整合素靶向胶束型美登素前药在体内有效抑制三阴性乳腺癌。
Int J Nanomedicine. 2017 Oct 27;12:7913-7921. doi: 10.2147/IJN.S146505. eCollection 2017.
7
A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.β-连环蛋白-TCF4 相互作用的小分子抑制剂在体外和体内抑制结直肠癌的生长。
EBioMedicine. 2017 Nov;25:22-31. doi: 10.1016/j.ebiom.2017.09.029. Epub 2017 Sep 27.
8
Alarming Burden of Triple-Negative Breast Cancer in India.印度三阴性乳腺癌负担令人震惊。
Clin Breast Cancer. 2018 Jun;18(3):e393-e399. doi: 10.1016/j.clbc.2017.07.013. Epub 2017 Jul 20.
9
Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis.印度三阴性乳腺癌的患病率:系统评价与荟萃分析。
J Glob Oncol. 2016 Jun 29;2(6):412-421. doi: 10.1200/JGO.2016.005397. eCollection 2016 Dec.
10
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.双重PI3K和Wnt信号通路抑制是针对三阴性乳腺癌的一种协同联合治疗方法。
NPJ Breast Cancer. 2017 Apr 26;3:17. doi: 10.1038/s41523-017-0016-8. eCollection 2017.